Performance of the Seattle Heart Failure Model in implantable defibrillator patients treated with cardiac resynchronization therapy

American Journal of Cardiology

Volumn 110, Issue 3, 2012, Pages 398-402

  Smith, Tim ^a   Levy, Wayne C ^b   Schaer, Beat A ^c   Balk, Aggie H H M ^a   Sticherling, Christian ^c   Jordaens, Luc ^a   Theuns, Dominic A M J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CLINICAL STUDY; DEFIBRILLATION; DEFIBRILLATOR; DISEASE MODEL; FEMALE; FOLLOW UP; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SEATTLE HEART FAILURE MODEL; SUDDEN DEATH; SURVIVAL;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT;

EID: 84863987448     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.03.038     Document Type: Article

References (17)

1. W.C. Levy, D. Mozaffarian, D.T. Linker, S.C. Sutradhar, S.D. Anker, A.B. Cropp, I. Anand, A. Maggioni, P. Burton, M.D. Sullivan, B. Pitt, P.A. Poole-Wilson, D.L. Mann, M. Packer The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433
2. D. Mozaffarian, S.D. Anker, I. Anand, D.T. Linker, M.D. Sullivan, J.G. Cleland, P.E. Carson, A.P. Maggioni, D.L. Mann, B. Pitt, P.A. Poole-Wilson, W.C. Levy Prediction of mode of death in heart failure: the Seattle Heart Failure Model Circulation 116 2007 392 398
3. W.C. Levy, K.L. Lee, A.S. Hellkamp, J.E. Poole, D. Mozaffarian, D.T. Linker, A.P. Maggioni, I. Anand, P.A. Poole-Wilson, D.P. Fishbein, G. Johnson, J. Anderson, D.B. Mark, G.H. Bardy Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population Circulation 120 2009 835 842
4. L.E. Hinkle Jr, H.T. Thaler Clinical classification of cardiac deaths Circulation 65 1982 457 464
5. H. Greenberg, R.B. Case, A.J. Moss, M.W. Brown, E.R. Carroll, M.L. Andrews Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II) J Am Coll Cardiol 43 2004 1459 1465
6. H.T. May, B.D. Horne, W.C. Levy, A.G. Kfoury, K.D. Rasmusson, D.T. Linker, D. Mozaffarian, J.L. Anderson, D.G. Renlund Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide Am J Cardiol 100 2007 697 700
7. A.P. Kalogeropoulos, V.V. Georgiopoulou, G. Giamouzis, A.L. Smith, S.A. Agha, S. Waheed, S. Laskar, J. Puskas, S. Dunbar, D. Vega, W.C. Levy, J. Butler Utility of the Seattle Heart Failure Model in patients with advanced heart failure J Am Coll Cardiol 53 2009 334 342
8. E.Z. Gorodeski, E.C. Chu, C.H. Chow, W.C. Levy, E. Hsich, R.C. Starling Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee Circ Heart Fail 3 2010 706 714
9. B. Ky, B. French, K. McCloskey, J.E. Rame, E. McIntosh, P. Shahi, D.L. Dries, W.H. Tang, A.H. Wu, J.C. Fang, R. Boxer, N.K. Sweitzer, W.C. Levy, L.R. Goldberg, M. Jessup, T.P. Cappola High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure Circ Heart Fail 4 2011 180 187
10. D.S. Lee, P.C. Austin, J.L. Rouleau, P.P. Liu, D. Naimark, J.V. Tu Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model JAMA 290 2003 2581 2587
11. D.S. Lee, J.V. Tu, P.C. Austin, P. Dorian, R. Yee, A. Chong, D.A. Alter, A. Laupacis Effect of cardiac and noncardiac conditions on survival after defibrillator implantation J Am Coll Cardiol 49 2007 2408 2415
12. S.M. Al-Khatib, M.A. Greiner, E.D. Peterson, A.F. Hernandez, K.A. Schulman, L.H. Curtis Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation 2002-2005 Circ Arrhythm Electrophysiol 1 2008 240 249
13. D.A. Theuns, B.A. Schaer, O.I. Soliman, D. Altmann, C. Sticherling, M.L. Geleijnse, S. Osswald, L. Jordaens The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality Europace 13 2011 62 69
14. J.G. Cleland, J.C. Daubert, E. Erdmann, N. Freemantle, D. Gras, L. Kappenberger, L. Tavazzi The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
15. M.R. Bristow, L.A. Saxon, J. Boehmer, S. Krueger, D.A. Kass, T. De Marco, P. Carson, L. DiCarlo, D. DeMets, B.G. White, D.W. DeVries, A.M. Feldman Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
16. A.J. Moss, W.J. Hall, D.S. Cannom, H. Klein, M.W. Brown, J.P. Daubert, N.A. Estes III, E. Foster, H. Greenberg, S.L. Higgins, M.A. Pfeffer, S.D. Solomon, D. Wilber, W. Zareba Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
17. A.S. Tang, G.A. Wells, M. Talajic, M.O. Arnold, R. Sheldon, S. Connolly, S.H. Hohnloser, G. Nichol, D.H. Birnie, J.L. Sapp, R. Yee, J.S. Healey, J.L. Rouleau Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395